https://www.indianpharmapost.com/samrat-pharmachem-reports-q4-fy21-pat-at-rs-155-cr-94642021-07-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/sandu-pharmaceuticals-q4fy21-pat-at-rs-4614-lakhs-94652021-07-02T00:00:00+05:30always0.9